Case report: ADHD and prognosis in tyrosinemia type 1

Case report: ADHD and prognosis in tyrosinemia type 1

Neurometabolic disorders such as tyrosinemia type 1 (TYRSN1) may interfere with brain metabolism and show symptoms of attention-deficit hyperactivity disorder (ADHD) in patients treated with the enzyme inhibitor nitisinone [2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione, NTBC]. It has bee...

Full description

Bibliographic Details
Main Authors: Helene Barone, Irene Bircow Elgen, Yngve Thomas Bliksrud, Eirik Vangsøy Hansen, Rita Rigmor Skavhellen, Magne Ivar Furevik, Jan Haavik
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Psychiatry
Subjects:
attention-deficit hyperactivity disorder
tyrosinemia type 1
treatment compliance
neurometabolic disorders
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1213590/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1213590/full

Similar Items